‘We are learning to live with Covid. India on verge of a structural bull market’
By Nikunj Dalmia I do not think the Covid crisis has caused the PE expansion or the EPS expansion in pharma. It was overdue. I have been shouting for two years, says Rakesh Jhunjhunwala, Partner, Rare Enterprises. Do you think markets right now have normalised or have we extended ourselves?There is only worry and there … Read more